0001387131-23-009036.txt : 20230829 0001387131-23-009036.hdr.sgml : 20230829 20230728172252 ACCESSION NUMBER: 0001387131-23-009036 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 CORRESP 1 filename1.htm

Adamis Pharmaceuticals Corporation

11683 El Camino Real, Suite 300

San Diego, CA 92103

 

July 28, 2023

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Re:        

Adamis Pharmaceuticals Corporation

Registration Statement on Form S-3 (No. 333-273233)

Filed on July 13, 2023

 

Acceleration Request

Requested Date:

July 31, 2023

Requested Time:

5:30 P.M. Eastern Time

 

To Whom it May Concern:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Adamis Pharmaceuticals Corporation (the "Company") hereby requests that the effective date of the above referenced registration statement, as amended (the “Registration Statement”), be accelerated to July 31, 2023, at 5:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Weintraub Tobin Chediak Coleman Grodin, law corporation, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Securities Act of 1933, as amended.

 

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Weintraub Tobin, by calling Kevin Kelso at (916) 558-6110.

 

Very truly yours,

 

 

Adamis Pharmaceuticals Corporation

 

By:      

/s/ David J. Marguglio

David J. Marguglio

President